{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:59:00Z","timestamp":1758121140656,"version":"3.37.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T00:00:00Z","timestamp":1556928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s40266-019-00676-7","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T13:14:56Z","timestamp":1557148496000},"page":"581-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-7902","authenticated-orcid":false,"given":"Erminia","family":"Ridolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kihlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Pellicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Nizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pucciarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Incorvaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,4]]},"reference":[{"issue":"71","key":"676_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0002-9394(53)92176-X","volume":"36","author":"MJ Hogan","year":"1953","unstructured":"Hogan MJ. Atopic keratoconjunctivitis. Am J Ophthalmol. 1953;36(71):937\u201347.","journal-title":"Am J Ophthalmol."},{"issue":"5","key":"676_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/ACI.0b013e3282ef868b","volume":"7","author":"S Bonini","year":"2007","unstructured":"Bonini S, Gramiccioni C, Bonini M, Bresciani M. Practical approach to diagnosis and treatment of ocular allergy: a 1-year systematic review. Curr Opin Allergy Clin Immunol. 2007;7(5):446\u20139.","journal-title":"Curr Opin Allergy Clin Immunol."},{"issue":"3","key":"676_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jaad.2013.10.036","volume":"70","author":"JJ Chen","year":"2014","unstructured":"Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: a review. J Am Acad Dermatol. 2014;70(3):569\u201375.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"676_CR4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.1995.tb02710.x","volume":"133","author":"K Yoneda","year":"1995","unstructured":"Yoneda K, Okamoto H, Wada Y, Morita K, Takahashi M, Ogura Y, et al. Atopic retinal detachment: report of four cases and a review of the literature. Br J Dermatol. 1995;133(4):586\u201391.","journal-title":"Br J Dermatol."},{"issue":"4","key":"676_CR5","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","volume":"126","author":"K Singh","year":"2010","unstructured":"Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988\u20131994. J Allergy Clin Immunol. 2010;126(4):778\u201383.","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"676_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1067\/mai.2000.111238","volume":"06","author":"L Bielory","year":"2000","unstructured":"Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol. 2000;06(6):1019\u201332.","journal-title":"J Allergy Clin Immunol."},{"issue":"8","key":"676_CR7","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0161-6420(90)32477-6","volume":"97","author":"CS Foster","year":"1990","unstructured":"Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology. 1990;97(8):992\u20131000.","journal-title":"Ophthalmology."},{"issue":"5","key":"676_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/02713688809031795","volume":"7","author":"SD Trocme","year":"1988","unstructured":"Trocme SD, Bonini S, Barney NP, Bloch KJ, Allansmith MR. Late-phase reaction in topically induced ocular anaphylaxis in the rat. Curr Eye Res. 1988;7(5):437\u201343.","journal-title":"Curr Eye Res."},{"issue":"11","key":"676_CR9","first-page":"889","volume":"53","author":"L Oshinskie","year":"1982","unstructured":"Oshinskie L, Haine C. Atopic dermatitis and its ophthalmic complications. J Am Optom Assoc. 1982;53(11):889\u201394.","journal-title":"J Am Optom Assoc."},{"issue":"1","key":"676_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00004397-198502510-00005","volume":"25","author":"LF Rich","year":"1985","unstructured":"Rich LF, Hanifin JM. Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin. 1985;25(1):61\u201376.","journal-title":"Int Ophthalmol Clin."},{"issue":"1","key":"676_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1365-2222.2000.00699.x","volume":"30","author":"E Uchio","year":"2000","unstructured":"Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy. 2000;30(1):103\u20139.","journal-title":"Clin Exp Allergy."},{"issue":"5","key":"676_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/ACI.0b013e32833e16e4","volume":"10","author":"S Guglielmetti","year":"2010","unstructured":"Guglielmetti S, Dart JK, Calder V. Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2010;10(5):478\u201385.","journal-title":"Curr Opin Allergy Clin Immunol."},{"issue":"9","key":"676_CR13","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1046\/j.1365-2222.1999.00585.x","volume":"29","author":"VL Calder","year":"1999","unstructured":"Calder VL, Jolly G, Hingorani M, et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy. 1999;29(9):1214\u201322.","journal-title":"Clin Exp Allergy."},{"issue":"5","key":"676_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/ACI.0b013e3282ef8674","volume":"7","author":"A Leonardi","year":"2007","unstructured":"Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol. 2007;7(5):429\u201335.","journal-title":"Curr Opin Allergy Clin Immunol."},{"issue":"Suppl. 78","key":"676_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1398-9995.2004.00570.x","volume":"59","author":"S Bonini","year":"2004","unstructured":"Bonini S. Atopic keratoconjunctivitis. Allergy. 2004;59(Suppl. 78):71\u20133.","journal-title":"Allergy."},{"issue":"1","key":"676_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2222.2011.03858.x","volume":"42","author":"E Nivenius","year":"2012","unstructured":"Nivenius E, Van der Ploeg I, Gafvelin G, et al. Conjunctival provocation with airborne allergen in patients with atopic keratoconjunctivitis. Clin Exp Allergy. 2012;42(1):58\u201365.","journal-title":"Clin Exp Allergy."},{"issue":"3","key":"676_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.iac.2010.06.004","volume":"30","author":"L Bielory","year":"2010","unstructured":"Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin N Am. 2010;30(3):323\u201336.","journal-title":"Immunol Allergy Clin N Am."},{"issue":"6 Pt 1","key":"676_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0091-6749(97)70279-3","volume":"100","author":"DP Metz","year":"1997","unstructured":"Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol. 1997;100(6 Pt 1):817\u201324.","journal-title":"J Allergy Clin Immunol."},{"key":"676_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23071665","author":"W Ding","year":"2018","unstructured":"Ding W, Zou GL, Zhang W, et al. Interleukin-33: its emerging role in allergic diseases. Molecules. 2018. \n                    https:\/\/doi.org\/10.3390\/molecules23071665\n                    \n                  .","journal-title":"Molecules."},{"key":"676_CR20","first-page":"23","volume":"6","author":"J Lin","year":"2013","unstructured":"Lin J, Zhao GQ, Wang Q, et al. Regulation of interleukin 33\/ST2 signaling of human corneal epithelium in allergic diseases. Int J Ophthalmol. 2013;6:23\u20139.","journal-title":"Int J Ophthalmol."},{"issue":"3","key":"676_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0161-6420(02)01767-0","volume":"110","author":"A Leonardi","year":"2003","unstructured":"Leonardi A, Jose PJ, Zhan H, Calder VL. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology. 2003;110(3):487\u201392.","journal-title":"Ophthalmology."},{"key":"676_CR22","first-page":"192","volume":"11","author":"S Yamagami","year":"2005","unstructured":"Yamagami S, Ebihara N, Amano SY. Chemokine receptor gene expression in giant papillae of atopic keratoconjunctivitis. Mol Vis. 2005;11:192\u2013200.","journal-title":"Mol Vis."},{"issue":"7","key":"676_CR23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00417-005-0168-3","volume":"244","author":"N Kitaichi","year":"2006","unstructured":"Kitaichi N, Shimizu T, Honda A, et al. Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis. Graefes Arch Clin Exp Ophthalmol. 2006;244(7):825\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"10","key":"676_CR24","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/exd.12520","volume":"23","author":"C Yasuda","year":"2014","unstructured":"Yasuda C, Enomoto A, Ishiwatari S, et al. Macrophage migration inhibitory factor (MIF) in the stratum corneum: a marker of the local severity of atopic dermatitis. Exp Dermatol. 2014;23(10):764\u20136.","journal-title":"Exp Dermatol."},{"issue":"1","key":"676_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00004397-200343010-00008","volume":"43","author":"H Zhan","year":"2003","unstructured":"Zhan H, Smith L, Calder V, Buckley R, Lightman S. Clinical and immunological features of atopic keratoconjunctivitis. Int Ophthalmol Clin. 2003;43(1):59\u201371.","journal-title":"Int Ophthalmol Clin."},{"issue":"2","key":"676_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0161-6420(92)31995-5","volume":"99","author":"SJ Tuft","year":"1992","unstructured":"Tuft SJ, Ramakrishnan M, Seal DV, Kemeny DM, Buckley RJ. Role of Staphylococcus aureus in chronic allergic conjunctivitis. Ophthalmology. 1992;99(2):180\u20134.","journal-title":"Ophthalmology."},{"issue":"1","key":"676_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0021-5155(98)00061-6","volume":"43","author":"M Dogru","year":"1999","unstructured":"Dogru M, Nakagawa N, Tetsumoto K, Katakami C, Yamamoto M. Ocular surface disease in atopic dermatitis. Jpn J Ophthalmol. 1999;43(1):53\u20137.","journal-title":"Jpn J Ophthalmol."},{"issue":"2","key":"676_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0002-9394(99)00295-0","volume":"129","author":"A Leonardi","year":"2000","unstructured":"Leonardi A, Borghesan F, Faggian D, Depaoli M, Secchi AG, Plebani M. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol. 2000;129(2):151\u20138.","journal-title":"Am J Ophthalmol."},{"issue":"5","key":"676_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.ico.0000114836.13127.45","volume":"23","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Dogru M, Takano Y, et al. The relation of conjunctival and corneal findings in severe ocular allergies. Cornea. 2004;23(5):464\u20137.","journal-title":"Cornea."},{"issue":"2","key":"676_CR30","first-page":"267","volume":"95","author":"D Easty","year":"1975","unstructured":"Easty D, Entwistle C, Funk A, Witcher J. Herpes simplex keratitis and keratoconus in the atopic patient: a clinical and immunological study. Trans Ophthalmol Soc U K. 1975;95(2):267\u201376.","journal-title":"Trans Ophthalmol Soc U K."},{"key":"676_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bjo.49.2.96","volume":"49","author":"RM Ingram","year":"1965","unstructured":"Ingram RM. Retinal detachment associated with atopic dermatitis and cataract. Br J Ophthalmol. 1965;49:96\u20137.","journal-title":"Br J Ophthalmol."},{"issue":"4","key":"676_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/00128071-200809040-00003","volume":"9","author":"JM Spergel","year":"2008","unstructured":"Spergel JM. Immunology and treatment of atopic dermatitis. Am J Clin Dermatol. 2008;9(4):233\u201344.","journal-title":"Am J Clin Dermatol."},{"key":"676_CR33","first-page":"1611","volume":"15","author":"TH Wakamatsu","year":"2009","unstructured":"Wakamatsu TH, Okada N, Kojima T, Matsumoto Y, Ibrahim OM, Dogru M, et al. Evaluation of conjunctival inflammatory status by confocal scanning laser microscopy and conjunctival brush cytology in patients with atopic keratoconjunctivitis (AKC). Mol Vis. 2009;15:1611\u20139.","journal-title":"Mol Vis."},{"issue":"2","key":"676_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/alr.22073","volume":"8","author":"SK Wise","year":"2018","unstructured":"Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108\u2013352.","journal-title":"Int Forum Allergy Rhinol."},{"issue":"1","key":"676_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2045-7022-1-11","volume":"1","author":"V Cardona","year":"2011","unstructured":"Cardona V, Guilarte M, Luengo O, Labrador-Horrillo M, Sala-Cunill A, Garriga T. Allergic diseases in the elderly. Clin Transl Allergy. 2011;1(1):11.","journal-title":"Clin Transl Allergy."},{"issue":"6","key":"676_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2165\/00002512-199812060-00006","volume":"12","author":"RM Seymour","year":"1998","unstructured":"Seymour RM, Routledge PA. Important drug-drug interactions in the elderly. Drugs Aging. 1998;12(6):485\u201394.","journal-title":"Drugs Aging."},{"issue":"5","key":"676_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/ACI.0000000000000299","volume":"16","author":"M Shaker","year":"2016","unstructured":"Shaker M, Salcone E. An update on ocular allergy. Curr Opin Allergy Clin Immunol. 2016;16(5):505\u201310.","journal-title":"Curr Opin Allergy Clin Immunol."},{"issue":"2","key":"676_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1081-1206(10)62590-2","volume":"82","author":"FE Simons","year":"1999","unstructured":"Simons FE, Fraser TG, Maher J, Pillay N, Simons KJ. Central nervous system effects of H1-receptor antagonists in the elderly. Ann Allergy Asthma Iimmunol. 1999;82(2):157\u201360.","journal-title":"Ann Allergy Asthma Iimmunol."},{"issue":"9","key":"676_CR39","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/ndt\/gfq827","volume":"26","author":"G Breton","year":"2011","unstructured":"Breton G, Froissart M, Janus N, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function: the three-city population-based study. Nephrol Dial Transplant. 2011;26(9):2852\u20139.","journal-title":"Nephrol Dial Transplant."},{"issue":"Suppl. 9A","key":"676_CR40","doi-asserted-by":"publisher","first-page":"38s","DOI":"10.1016\/S0002-9343(02)01436-5","volume":"113","author":"FE Simons","year":"2002","unstructured":"Simons FE. Comparative pharmacology of H1 antihistamines: clinical relevance. Am J Med. 2002;113(Suppl. 9A):38s\u201346s.","journal-title":"Am J Med."},{"issue":"1","key":"676_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12948-015-0008-x","volume":"13","author":"E Ridolo","year":"2015","unstructured":"Ridolo E, Montagni M, Bonzano L, Incorvaia C, Canonica GW. Bilastine: new insight into antihistamine treatment. Clin Mol Allergy. 2015;13(1):1.","journal-title":"Clin Mol Allergy."},{"issue":"1","key":"676_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1185\/03007995.2011.648263","volume":"28","author":"J Bousquet","year":"2012","unstructured":"Bousquet J, Ansotegui I, Canonica GW, et al. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review. Curr Med Res Opin. 2012;28(1):131\u20139.","journal-title":"Curr Med Res Opin."},{"issue":"4","key":"676_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2500\/aap.2018.39.4136","volume":"39","author":"A Sologuren","year":"2018","unstructured":"Sologuren A, Vinas R, Cordon E, et al. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and\/or urticaria. Allergy Asthma Proc. 2018;39(4):299\u2013304.","journal-title":"Allergy Asthma Proc."},{"issue":"Suppl. 100","key":"676_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/all.12531","volume":"70","author":"J Mullol","year":"2015","unstructured":"Mullol J, Bousquet J, Bachert C, et al. Update on rupatadine in the management of allergic disorders. Allergy. 2015;70(Suppl. 100):1\u201324.","journal-title":"Allergy."},{"issue":"12","key":"676_CR45","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2165\/11205880-000000000-00000","volume":"70","author":"KA Lyseng-Williamson","year":"2010","unstructured":"Lyseng-Williamson KA. Oral bepotastine: in allergic disorders. Drugs. 2010;70(12):1579\u201391.","journal-title":"Drugs."},{"issue":"3","key":"676_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11882-019-0844-8","volume":"19","author":"L Bielory","year":"2019","unstructured":"Bielory L, Schoenberg D. Emerging therapeutics for ocular surface disease. Curr Allergy Asthma Rep. 2019;19(3):16.","journal-title":"Curr Allergy Asthma Rep."},{"issue":"7","key":"676_CR47","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/02713680802149115","volume":"33","author":"L Attas-Fox","year":"2008","unstructured":"Attas-Fox L, Barkana Y, Iskhakov V, et al. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study. Curr Eye Res. 2008;33(7):545\u20139.","journal-title":"Curr Eye Res."},{"issue":"3","key":"676_CR48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00002512-200623030-00003","volume":"23","author":"A Flammiger","year":"2006","unstructured":"Flammiger A, Maibach H. Drug dosage in the elderly: dermatological drugs. Drugs Aging. 2006;23(3):203\u201315.","journal-title":"Drugs Aging."},{"issue":"6","key":"676_CR49","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1212\/WNL.47.6.1396","volume":"47","author":"PA Keenan","year":"1996","unstructured":"Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology. 1996;47(6):1396\u2013402.","journal-title":"Neurology."},{"issue":"9","key":"676_CR50","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1525-1497.2002.10649.x","volume":"17","author":"D Blackburn","year":"2002","unstructured":"Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Int Med. 2002;17(9):717\u201320.","journal-title":"J Gen Int Med."},{"issue":"4","key":"676_CR51","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ophtha.2008.12.001","volume":"116","author":"JJ Wang","year":"2009","unstructured":"Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology. 2009;116(4):652\u20137.","journal-title":"Ophthalmology."},{"issue":"1","key":"676_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMcp1012926","volume":"365","author":"RS Weinstein","year":"2011","unstructured":"Weinstein RS. Clinical practice: glucocorticoid-induced bone disease. N Engl J Med. 2011;365(1):62\u201370.","journal-title":"N Engl J Med."},{"issue":"4","key":"676_CR53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0165-0327(83)90022-8","volume":"5","author":"DA Lewis","year":"1983","unstructured":"Lewis DA, Smith RE. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord. 1983;5(4):319\u201332.","journal-title":"J Affect Disord."},{"issue":"4","key":"676_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00005053-197904000-00006","volume":"167","author":"RC Hall","year":"1979","unstructured":"Hall RC, Popkin MK, Stickney SK, Gardner ER. Presentation of the steroid psychoses. J Nerv Ment Dis. 1979;167(4):229\u201336.","journal-title":"J Nerv Ment Dis."},{"issue":"4","key":"676_CR55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0192-0561(96)84506-1","volume":"18","author":"CI Ezeamuzie","year":"1996","unstructured":"Ezeamuzie CI. Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506. Int J Iimmunopharmacol. 1996;18(4):263\u201370.","journal-title":"Int J Iimmunopharmacol."},{"issue":"4","key":"676_CR56","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bjo.2005.082461","volume":"90","author":"M Daniell","year":"2006","unstructured":"Daniell M, Constantinou M, Vu HT, Taylor HR. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Ophthalmol. 2006;90(4):461\u20134.","journal-title":"Br J Ophthalmol."},{"issue":"2 Pt 1","key":"676_CR57","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1399-3038.2009.00948.x","volume":"21","author":"R Tesse","year":"2010","unstructured":"Tesse R, Spadavecchia L, Fanelli P, et al. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children. Pediatr Allergy Immunol. 2010;21(2 Pt 1):330\u20135.","journal-title":"Pediatr Allergy Immunol."},{"issue":"9","key":"676_CR58","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","volume":"105","author":"M Hingorani","year":"1998","unstructured":"Hingorani M, Moodaley L, Calder VL, Buckley RJ, Lightman S. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Ophthalmology. 1998;105(9):1715\u201320.","journal-title":"Ophthalmology."},{"issue":"2","key":"676_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1067\/mjd.2002.120942","volume":"46","author":"P Nghiem","year":"2002","unstructured":"Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol. 2002;46(2):228\u201341.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"676_CR60","doi-asserted-by":"publisher","first-page":"988-92.e5","DOI":"10.1016\/j.ophtha.2007.07.025","volume":"115","author":"D Miyazaki","year":"2008","unstructured":"Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology. 2008;115(6):988-92.e5.","journal-title":"Ophthalmology."},{"issue":"8","key":"676_CR61","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/S0161-6420(97)30144-4","volume":"104","author":"T Hoang-Xuan","year":"1997","unstructured":"Hoang-Xuan T, Prisant O, Hannouche D, Robin H. Systemic cyclosporine A in severe atopic keratoconjunctivitis. Ophthalmology. 1997;104(8):1300\u20135.","journal-title":"Ophthalmology."},{"issue":"10","key":"676_CR62","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/01.ico.0000240091.11854.14","volume":"25","author":"T Stumpf","year":"2006","unstructured":"Stumpf T, Luqmani N, Sumich P, Cook S, Tole D. Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis. Cornea. 2006;25(10):1147\u20139.","journal-title":"Cornea."},{"key":"676_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2018.12.002","author":"S Jabbehdari","year":"2018","unstructured":"Jabbehdari S, Starnes TW, Kurji KH, Eslani M, Cortina MS, Holland EJ, et al. Management of advanced ocular surface disease in patients with severe atopic keratoconjunctivitis. Ocul Surf. 2018. \n                    https:\/\/doi.org\/10.1016\/j.jtos.2018.12.002\n                    \n                  \n                           (Epub ahead of print).","journal-title":"Ocul Surf."},{"issue":"3","key":"676_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","volume":"149","author":"E Daniel","year":"2010","unstructured":"Daniel E, Thorne JE, Newcomb CW, Pujari SS, Ka\u00e7maz RO, Levy-Clarke GA, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149(3):423\u201332.","journal-title":"Am J Ophthalmol."},{"issue":"11","key":"676_CR65","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","volume":"116","author":"S Gangaputra","year":"2009","unstructured":"Gangaputra S, Newcomb CW, Liesegang TL. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116(11):2188\u201398.","journal-title":"Ophthalmology."},{"key":"676_CR66","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","volume":"148","author":"S Pasadhika","year":"2009","unstructured":"Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148:500\u20139.","journal-title":"Am J Ophthalmol."},{"issue":"10","key":"676_CR67","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","volume":"115","author":"A Galor","year":"2008","unstructured":"Galor A, Jabs DA, Leder HA. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology. 2008;115(10):1826\u201332.","journal-title":"Ophthalmology."},{"issue":"4","key":"676_CR68","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tjo.2015.03.004","volume":"5","author":"DM Hornbeak","year":"2015","unstructured":"Hornbeak DM, Thorne JE. Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention. Taiwan J Ophthalmol. 2015;5(4):156\u201363.","journal-title":"Taiwan J Ophthalmol."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00676-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-019-00676-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00676-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T23:04:33Z","timestamp":1588460673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-019-00676-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,4]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1007\/s40266-019-00676-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"type":"print","value":"1170-229X"},{"type":"electronic","value":"1179-1969"}],"subject":[],"published":{"date-parts":[[2019,5,4]]},"assertion":[{"value":"4 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Erminia Ridolo, Kihlgren P, Pellicelli I, Nizi MC, Pucciarini F, and Incorvaia C have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}